{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T22:36:21Z","timestamp":1794436581541,"version":"4.9.1"},"reference-count":98,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T00:00:00Z","timestamp":1724284800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.biopha.2024.117351","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T08:56:33Z","timestamp":1725008193000},"page":"117351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Mutant P53 modulation by cryptolepine through cell cycle arrest and apoptosis in triple negative breast cancer"],"prefix":"10.1016","volume":"179","author":[{"given":"Hina","family":"Qayoom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manzoor A.","family":"Mir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.biopha.2024.117351_bib1","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1158\/2159-8290.CD-18-1177","article-title":"\"Insights into molecular classifications of triple-negative breast cancer: improving patient selection for treatment\"","volume":"vol. 9","author":"Garrido-Castro","year":"2019","journal-title":"Cancer Discov."},{"issue":"6","key":"10.1016\/j.biopha.2024.117351_bib2","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1200\/JGO.2016.005397","article-title":"\"Prevalence of triple-negative breast cancer in india: systematic review and meta-analysis\"","volume":"vol. 2","author":"Sandhu","year":"2016","journal-title":"J. Glob. Oncol."},{"issue":"20","key":"10.1016\/j.biopha.2024.117351_bib3","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1056\/NEJMra1001389","article-title":"\"Triple-negative breast cancer\"","volume":"vol. 363","author":"Foulkes","year":"2010","journal-title":"N. Engl. J. Med"},{"issue":"Suppl 6","key":"10.1016\/j.biopha.2024.117351_bib4","doi-asserted-by":"crossref","first-page":"vi7","DOI":"10.1093\/annonc\/mds187","article-title":"\"Triple-negative breast cancer: epidemiological considerations and recommendations\"","volume":"vol. 23","author":"Boyle","year":"2012","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.biopha.2024.117351_bib5","doi-asserted-by":"crossref","unstructured":"Qayoom H, Bashir S, Khan R, Hussain MU, Wani S, Mir MA. Exploring SALL4 as a significant prognostic marker in breast cancer and its association with progression pathways involved in cancer genesis. Computational Biology and Chemistry. 2024 Oct 1;112:108164.","DOI":"10.1016\/j.compbiolchem.2024.108164"},{"key":"10.1016\/j.biopha.2024.117351_bib6","article-title":"\"Molecular profiling of metastatic breast cancer (MBC) and target-based therapeutic matching in an Asian tertiary phase I oncology unit\", ed: American Society","author":"Walsh","year":"2020","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.biopha.2024.117351_bib7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.breast.2022.08.010","article-title":"\"Current and future burden of breast cancer: Global statistics for 2020 and 2040\"","volume":"vol. 66","author":"Arnold","year":"2022","journal-title":"Breast"},{"key":"10.1016\/j.biopha.2024.117351_bib8","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.semcancer.2020.06.005","article-title":"\"Pathology of triple negative breast cancer\"","volume":"vol. 72","author":"Borri","year":"2021","journal-title":"Semin Cancer Biol."},{"issue":"12","key":"10.1016\/j.biopha.2024.117351_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13122978","article-title":"\"Pathogenesis and Potential Therapeutic Targets for Triple-Negative Breast Cancer\"","volume":"vol. 13","author":"Li","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.biopha.2024.117351_bib10","doi-asserted-by":"crossref","unstructured":"Jan N, Qayoom H, Alkhanani M, Almilaibary A, Mir MA. Elucidation of interleukin-19 as a therapeutic target for breast cancer by computational analysis and experimental validation. Saudi Journal of Biological Sciences. 2023 Sep 1;30(9):103774.","DOI":"10.1016\/j.sjbs.2023.103774"},{"issue":"7418","key":"10.1016\/j.biopha.2024.117351_bib11","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nature11412","article-title":"Comprehensive molecular portraits of human breast tumours\"","volume":"vol. 490","year":"2012","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.biopha.2024.117351_bib12","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.tig.2011.12.002","article-title":"\"The p53 network: cellular and systemic DNA damage responses in aging and cancer\"","volume":"vol. 28","author":"Reinhardt","year":"2012","journal-title":"Trends Genet"},{"issue":"10","key":"10.1016\/j.biopha.2024.117351_bib13","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.ctrv.2014.10.004","article-title":"\"p53 as a target for the treatment of cancer\"","volume":"vol. 40","author":"Duffy","year":"2014","journal-title":"Cancer Treat. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2024.117351_bib14","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.tips.2010.11.004","article-title":"\"Reactivation of p53: from peptides to small molecules\"","volume":"vol. 32","author":"Brown","year":"2011","journal-title":"Trends Pharm. Sci."},{"issue":"6381","key":"10.1016\/j.biopha.2024.117351_bib15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/358015a0","article-title":"\"Cancer. p53, guardian of the genome\"","volume":"vol. 358","author":"Lane","year":"1992","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.biopha.2024.117351_bib16","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0092-8674(00)81871-1","article-title":"\"p53, the cellular gatekeeper for growth and division\"","volume":"vol. 88","author":"Levine","year":"1997","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.biopha.2024.117351_bib17","doi-asserted-by":"crossref","first-page":"a001883","DOI":"10.1101\/cshperspect.a001883","article-title":"\"Tumor suppressive functions of p53\"","volume":"vol. 1","author":"Zilfou","year":"2009","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.biopha.2024.117351_bib18","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.semcancer.2020.07.005","article-title":"\"Targeting p53 for the treatment of cancer\"","volume":"vol. 79","author":"Duffy","year":"2022","journal-title":"Semin Cancer Biol."},{"issue":"12","key":"10.1016\/j.biopha.2024.117351_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/cancers9120172","article-title":"\"PRIMA-1 and PRIMA-1(Met) (APR-246): From Mutant\/Wild Type p53 Reactivation to Unexpected Mechanisms Underlying Their Potent Anti-Tumor Effect in Combinatorial Therapies\"","volume":"vol. 9","author":"Perdrix","year":"2017","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.biopha.2024.117351_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/cells10010098","article-title":"\"Antitumor Effects of PRIMA-1 and PRIMA-1(Met) (APR246) in Hematological Malignancies: Still a Mutant P53-Dependent Affair?\"","volume":"vol. 10","author":"Menichini","year":"2021","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.biopha.2024.117351_bib21","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.2353\/ajpath.2009.080545","article-title":"\"Epithelial-mesenchymal transition: a cancer researcher's conceptual friend and foe\"","volume":"vol. 174","author":"Klymkowsky","year":"2009","journal-title":"Am. J. Pathol."},{"issue":"98","key":"10.1016\/j.biopha.2024.117351_bib22","doi-asserted-by":"crossref","first-page":"37137","DOI":"10.18632\/oncotarget.26440","article-title":"\"The molecular mechanism of action of methylene quinuclidinone and its effects on the structure of p53 mutants\"","volume":"vol. 9","author":"Omar","year":"2018","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.biopha.2024.117351_bib23","doi-asserted-by":"crossref","first-page":"a026104","DOI":"10.1101\/cshperspect.a026104","article-title":"\"The cell-cycle arrest and apoptotic functions of p53 in tumor initiation and progression\"","volume":"vol. 6","author":"Chen","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med"},{"issue":"30","key":"10.1016\/j.biopha.2024.117351_bib24","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.2174\/1381612824666180926095709","article-title":"\"Role of p53 Gene in Breast cancer: focus on mutation spectrum and therapeutic strategies\"","volume":"vol. 24","author":"Kaur","year":"2018","journal-title":"Curr. Pharm. Des."},{"issue":"3","key":"10.1016\/j.biopha.2024.117351_bib25","doi-asserted-by":"crossref","DOI":"10.1186\/bcr1675","article-title":"\"TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer\"","volume":"vol. 9","author":"Langer\u00f8d","year":"2007","journal-title":"Breast Cancer Res"},{"issue":"7403","key":"10.1016\/j.biopha.2024.117351_bib26","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nature10933","article-title":"\"The clonal and mutational evolution spectrum of primary triple-negative breast cancers\"","volume":"vol. 486","author":"Shah","year":"2012","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.biopha.2024.117351_bib27","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1200\/JCO.2009.22.4725","article-title":"\"Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer\"","volume":"vol. 28","author":"Silver","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"19","key":"10.1016\/j.biopha.2024.117351_bib28","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1073\/pnas.191367098","article-title":"\"Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications\"","volume":"vol. 98","author":"S\u00f8rlie","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.biopha.2024.117351_bib29","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1211\/jpp.59.6.0017","article-title":"\"Recent developments in naturally derived antimalarials: cryptolepine analogues\"","volume":"vol. 59","author":"Wright","year":"2007","journal-title":"J. Pharm. Pharm."},{"issue":"8","key":"10.1016\/j.biopha.2024.117351_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008489","article-title":"\"In vitro and in vivo growth inhibitory activities of cryptolepine hydrate against several Babesia species and Theileria equi\"","volume":"vol. 14","author":"Batiha","year":"2020","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.biopha.2024.117351_bib31","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12936-016-1137-5","article-title":"\"Synergistic anti-malarial action of cryptolepine and artemisinins\"","volume":"vol. 15","author":"Forkuo","year":"2016","journal-title":"Malar. J."},{"key":"10.1016\/j.biopha.2024.117351_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.875647","article-title":"\"Semi-Synthetic Analogues of Cryptolepine as a Potential Source of Sustainable Drugs for the Treatment of Malaria, Human African Trypanosomiasis, and Cancer\"","volume":"vol. 13","author":"Abacha","year":"2022","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2024.117351_bib33","first-page":"177","article-title":"\"Recent Advances in the Chemistry and Pharmacology of Cryptolepine\"","volume":"vol. 115","author":"Shnyder","year":"2021","journal-title":"Prog. Chem. Org. Nat. Prod."},{"issue":"12","key":"10.1016\/j.biopha.2024.117351_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/molecules21121758","article-title":"\"Cryptolepine, a Plant Alkaloid, Inhibits the Growth of Non-Melanoma Skin Cancer Cells through Inhibition of Topoisomerase and Induction of DNA Damage\"","volume":"vol. 21","author":"Pal","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2024.117351_bib35","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/978-1-61779-080-5_20","article-title":"\"Cell sensitivity assays: the MTT assay\"","volume":"vol. 731","author":"van Meerloo","year":"2011","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2024.117351_bib36","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13046-018-0694-6","article-title":"\"14, 15-EET induces breast cancer cell EMT and cisplatin resistance by up-regulating integrin \u03b1v\u03b23 and activating FAK\/PI3K\/AKT signaling\"","volume":"vol. 37","author":"Luo","year":"2018","journal-title":"J. Exp. Clin. Cancer Res"},{"issue":"1","key":"10.1016\/j.biopha.2024.117351_bib37","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0048-9697(99)00479-9","article-title":"\"Improving the reproducibility of the MCF-7 cell proliferation assay for the detection of xenoestrogens\"","volume":"vol. 248","author":"Payne","year":"2000","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.biopha.2024.117351_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-6960-9_1","article-title":"\"Basic Colorimetric Proliferation Assays: MTT, WST, and Resazurin\"","volume":"vol. 1601","author":"Pr\u00e4bst","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.biopha.2024.117351_bib39","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/978-1-4939-7401-6_8","article-title":"\"In vitro tumorigenic assay: colony forming assay for cancer stem cells\"","author":"Rajendran","year":"2018","journal-title":"Cancer Stem Cells.: Methods Protoc."},{"issue":"8","key":"10.1016\/j.biopha.2024.117351_bib40","article-title":"\"Measuring survival of adherent cells with the colony-forming assay\"","volume":"vol. 2016","author":"Crowley","year":"2016","journal-title":"Cold Spring Harb. Protoc."},{"key":"10.1016\/j.biopha.2024.117351_bib41","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3389\/fonc.2018.00633","article-title":"\"Migratory metrics of wound healing: a quantification approach for in vitro scratch assays\"","volume":"vol. 8","author":"Varankar","year":"2018","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.biopha.2024.117351_bib42","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nprot.2007.30","article-title":"\"In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro\"","volume":"vol. 2","author":"Liang","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.biopha.2024.117351_bib43","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/978-1-0716-2736-5_14","article-title":"\"Analysis of Cell Cycle by Flow Cytometry\"","volume":"vol. 2579","author":"Maadi","year":"2022","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.biopha.2024.117351_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1478-811X-9-8","article-title":"\"A protocol to assess cell cycle and apoptosis in human and mouse pluripotent cells\"","volume":"vol. 9","author":"Edel","year":"2011","journal-title":"Cell Commun. Signal."},{"issue":"1","key":"10.1016\/j.biopha.2024.117351_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052011","article-title":"\"Structure prediction and validation of the ERK8 kinase domain\"","volume":"vol. 8","author":"Strambi","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.biopha.2024.117351_bib46","doi-asserted-by":"crossref","DOI":"10.1002\/pro.4557","article-title":"\"Target-template relationships in protein structure prediction and their effect on the accuracy of thermostability calculations\"","volume":"vol. 32","author":"Lihan","year":"2023","journal-title":"Protein Sci."},{"issue":"16","key":"10.1016\/j.biopha.2024.117351_bib47","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"\"AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility\"","volume":"vol. 30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"issue":"W1","key":"10.1016\/j.biopha.2024.117351_bib48","doi-asserted-by":"crossref","first-page":"W365","DOI":"10.1093\/nar\/gkx407","article-title":"\"HDOCK: a web server for protein-protein and protein-DNA\/RNA docking based on a hybrid strategy\"","volume":"vol. 45","author":"Yan","year":"2017","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"10.1016\/j.biopha.2024.117351_bib49","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"\"Comparison of simple potential functions for simulating liquid water\"","volume":"vol. 79","author":"Jorgensen","year":"1983","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.biopha.2024.117351_bib50","doi-asserted-by":"crossref","unstructured":"K.J. Bowers et al., \"Scalable algorithms for molecular dynamics simulations on commodity clusters\", 2006, pp. 84-es.","DOI":"10.1145\/1188455.1188544"},{"key":"10.1016\/j.biopha.2024.117351_bib51","unstructured":"E. Chow et al., \"Desmond performance on a cluster of multicore processors\", DE Shaw Research Technical Report DESRES\/TR--2008-01, 2008."},{"issue":"5","key":"10.1016\/j.biopha.2024.117351_bib52","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1021\/ct900587b","article-title":"\"Prediction of Absolute Solvation Free Energies using Molecular Dynamics Free Energy Perturbation and the OPLS Force Field\"","volume":"vol. 6","author":"Shivakumar","year":"2010","journal-title":"J. Chem. Theory Comput."},{"issue":"5","key":"10.1016\/j.biopha.2024.117351_bib53","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1063\/1.467468","article-title":"\"Constant pressure molecular dynamics algorithms\"","volume":"vol. 101","author":"Martyna","year":"1994","journal-title":"J. Chem. Phys."},{"issue":"4","key":"10.1016\/j.biopha.2024.117351_bib54","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1063\/1.463940","article-title":"\"Nos\u00e9\u2013Hoover chains: The canonical ensemble via continuous dynamics\"","volume":"vol. 97","author":"Martyna","year":"1992","journal-title":"J. Chem. Phys."},{"issue":"2-3","key":"10.1016\/j.biopha.2024.117351_bib55","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0010-4655(96)00016-1","article-title":"\"Ewald summation techniques in perspective: a survey\"","volume":"vol. 95","author":"Toukmaji","year":"1996","journal-title":"Comput. Phys. Commun."},{"issue":"6","key":"10.1016\/j.biopha.2024.117351_bib56","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/nprot.2008.68","article-title":"\"A rapid micro chromatin immunoprecipitation assay (microChIP)\"","volume":"vol. 3","author":"Dahl","year":"2008","journal-title":"Nat. Protoc."},{"issue":"7","key":"10.1016\/j.biopha.2024.117351_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041242","article-title":"\"Potential role for PAD2 in gene regulation in breast cancer cells\"","volume":"vol. 7","author":"Cherrington","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.biopha.2024.117351_bib58","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ab.2012.07.005","article-title":"\"7-Aminoactinomycin D for apoptosis staining in flow cytometry\"","volume":"vol. 429","author":"Zembruski","year":"2012","journal-title":"Anal. Biochem"},{"key":"10.1016\/j.biopha.2024.117351_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120402","article-title":"\"Telomerase inhibition on acute myeloid leukemia stem cell induced apoptosis with both intrinsic and extrinsic pathways\"","volume":"vol. 295","author":"Rafat","year":"2022","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.biopha.2024.117351_bib60","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/cyto.990150409","article-title":"\"A fast kinetic method for assessing mitochondrial membrane potential in isolated hepatocytes with rhodamine 123 and flow cytometry\"","volume":"vol. 15","author":"Juan","year":"1994","journal-title":"Cytom.: J. Int. Soc. Anal. Cytol."},{"key":"10.1016\/j.biopha.2024.117351_bib61","first-page":"221","article-title":"\"Visualization of mitochondrial membrane potential in mammalian cells\"","volume":"vol. 155","author":"Esteras","year":"2020"},{"issue":"1","key":"10.1016\/j.biopha.2024.117351_bib62","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/jmi.12133","article-title":"\"Cell-death assessment by fluorescent and nonfluorescent cytosolic and nuclear staining techniques\"","volume":"vol. 255","author":"Atale","year":"2014","journal-title":"J. Microsc."},{"issue":"4","key":"10.1016\/j.biopha.2024.117351_bib63","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/jre.12228","article-title":"\"Isolation and characterization of human mesenchymal stem cells from gingival connective tissue\"","volume":"vol. 50","author":"Jin","year":"2015","journal-title":"J. Periodontal Res."},{"issue":"2","key":"10.1016\/j.biopha.2024.117351_bib64","first-page":"175","article-title":"\"Comparative study of gavage and intraperitoneal administration of gamma-oryzanol in alleviation\/attenuation in a rat animal model of renal ischemia\/reperfusion-induced injury\"","volume":"vol. 24","author":"Bagheri","year":"2021","journal-title":"Iran. J. Basic Med Sci."},{"issue":"160","key":"10.1016\/j.biopha.2024.117351_bib65","doi-asserted-by":"crossref","DOI":"10.3791\/60682","article-title":"\"Detection of Total Reactive Oxygen Species in Adherent Cells by 2\u2032,7\u2032-Dichlorodihydrofluorescein Diacetate Staining\"","author":"Kim","year":"2020","journal-title":"J. Vis. Exp."},{"issue":"2","key":"10.1016\/j.biopha.2024.117351_bib66","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nprot.2006.83","article-title":"\"The single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction: twenty-something years on\"","volume":"vol. 1","author":"Chomczynski","year":"2006","journal-title":"Nat. Protoc."},{"issue":"12","key":"10.1016\/j.biopha.2024.117351_bib67","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.1167\/iovs.05-0632","article-title":"\"Expression and activation of STAT3 in ischemia-induced retinopathy\"","volume":"vol. 46","author":"Mechoulam","year":"2005","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2024.117351_bib68","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.reth.2023.04.004","article-title":"\"Granulocyte differentiation of rat bone marrow resident C-kit(+) hematopoietic stem cells induced by mesenchymal stem cells could be considered as new option in cell-based therapy\"","volume":"vol. 23","author":"Farahzadi","year":"2023","journal-title":"Regen. Ther."},{"issue":"18","key":"10.1016\/j.biopha.2024.117351_bib69","article-title":"\"Association of p53 expression with poor prognosis in patients with triple-negative breast invasive ductal carcinoma\"","volume":"vol. 98","author":"Li","year":"2019","journal-title":"Med. (Baltim. )"},{"key":"10.1016\/j.biopha.2024.117351_bib70","unstructured":"A.K. Farha, B.S. Geetha, S. Mangalam Nair, S.R. Dhanya, P.G. Latha, and P. Remani, \"Apoptosis mediated cytotoxicity induced by isodeoxyelephantopin on nasopharyngeal carcinoma cells\", 2013."},{"issue":"1-2","key":"10.1016\/j.biopha.2024.117351_bib71","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0304-3835(99)00280-3","article-title":"\"Clofilium, a potassium channel blocker, induces apoptosis of human promyelocytic leukemia (HL-60) cells via Bcl-2-insensitive activation of caspase-3\"","volume":"vol. 147","author":"Choi","year":"1999","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.biopha.2024.117351_bib72","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3390\/biom10030361","article-title":"\"Mutant p53-associated molecular mechanisms of ROS regulation in cancer cells\"","volume":"vol. 10","author":"Cordani","year":"2020","journal-title":"Biomolecules"},{"issue":"14","key":"10.1016\/j.biopha.2024.117351_bib73","doi-asserted-by":"crossref","first-page":"6982","DOI":"10.1158\/0008-5472.CAN-06-0511","article-title":"\"p73 or p53 directly regulates human p53 transcription to maintain cell cycle checkpoints\"","volume":"vol. 66","author":"Wang","year":"2006","journal-title":"Cancer Res"},{"issue":"21","key":"10.1016\/j.biopha.2024.117351_bib74","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13215350","article-title":"\"Molecular Classification of Breast Cancer Utilizing Long Non-Coding RNA (lncRNA) Transcriptomes Identifies Novel Diagnostic lncRNA Panel for Triple-Negative Breast Cancer\"","volume":"vol. 13","author":"Shaath","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"Suppl 6","key":"10.1016\/j.biopha.2024.117351_bib75","doi-asserted-by":"crossref","first-page":"vi46","DOI":"10.1093\/annonc\/mds195","article-title":"\"Optimal strategies for the treatment of metastatic triple-negative breast cancer with currently approved agents\"","volume":"vol. 23","author":"Andr\u00e9","year":"2012","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2024.117351_bib76","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026252","article-title":"\"TP53 Mutations in Breast and Ovarian Cancer\"","volume":"vol. 7","author":"Silwal-Pandit","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med"},{"issue":"2","key":"10.1016\/j.biopha.2024.117351_bib77","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1006\/bbrc.2001.4792","article-title":"\"Downregulation of the cdc2\/cyclin B protein kinase activity by binding of p53 to p34(cdc2)\"","volume":"vol. 283","author":"Ababneh","year":"2001","journal-title":"Biochem Biophys. Res Commun."},{"issue":"6","key":"10.1016\/j.biopha.2024.117351_bib78","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/cdd.2010.35","article-title":"\"p53-family proteins and their regulators: hubs and spokes in tumor suppression\"","volume":"vol. 17","author":"Collavin","year":"2010","journal-title":"Cell Death Differ."},{"issue":"5","key":"10.1016\/j.biopha.2024.117351_bib79","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S1097-2765(03)00424-6","article-title":"\"Regulation of BRCC, a holoenzyme complex containing BRCA1 and BRCA2, by a signalosome-like subunit and its role in DNA repair\"","volume":"vol. 12","author":"Dong","year":"2003","journal-title":"Mol. Cell"},{"issue":"3","key":"10.1016\/j.biopha.2024.117351_bib80","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1006\/jmbi.2000.3830","article-title":"\"The C-terminal regulatory domain of p53 contains a functional docking site for cyclin A\"","volume":"vol. 300","author":"Luciani","year":"2000","journal-title":"J. Mol. Biol."},{"issue":"3","key":"10.1016\/j.biopha.2024.117351_bib81","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nrc1819","article-title":"\"Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis\"","volume":"vol. 6","author":"Cully","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2024.117351_bib82","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3389\/fonc.2015.00288","article-title":"\"Targeting Oncogenic Mutant p53 for Cancer Therapy\"","volume":"vol. 5","author":"Parrales","year":"2015","journal-title":"Front Oncol."},{"issue":"3","key":"10.1016\/j.biopha.2024.117351_bib83","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ccr.2014.01.021","article-title":"\"Mutant p53 in cancer: new functions and therapeutic opportunities\"","volume":"vol. 25","author":"Muller","year":"2014","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.biopha.2024.117351_bib84","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/cdd.2013.17","article-title":"\"Two hot spot mutant p53 mouse models display differential gain of function in tumorigenesis\"","volume":"vol. 20","author":"Hanel","year":"2013","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.biopha.2024.117351_bib85","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1038\/s41467-018-06146-9","article-title":"\"Somatic Trp53 mutations differentially drive breast cancer and evolution of metastases\"","volume":"vol. 9","author":"Zhang","year":"2018","journal-title":"Nat. Commun."},{"issue":"16","key":"10.1016\/j.biopha.2024.117351_bib86","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13164088","article-title":"\"The Function of the Mutant p53-R175H in Cancer\"","volume":"vol. 13","author":"Chiang","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"16","key":"10.1016\/j.biopha.2024.117351_bib87","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1016\/j.febslet.2014.04.017","article-title":"\"Mutant p53 reactivation by small molecules makes its way to the clinic\"","volume":"vol. 588","author":"Bykov","year":"2014","journal-title":"FEBS Lett."},{"issue":"12","key":"10.1016\/j.biopha.2024.117351_bib88","doi-asserted-by":"crossref","first-page":"4262","DOI":"10.1074\/jbc.RA117.000950","article-title":"\"The curcumin analog HO-3867 selectively kills cancer cells by converting mutant p53 protein to transcriptionally active wildtype p53\"","volume":"vol. 293","author":"Madan","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"21","key":"10.1016\/j.biopha.2024.117351_bib89","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1038\/sj.onc.1208419","article-title":"\"PRIMA-1(MET) synergizes with cisplatin to induce tumor cell apoptosis\"","volume":"vol. 24","author":"Bykov","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2024.117351_bib90","doi-asserted-by":"crossref","unstructured":"Haq BU, Qayoom H, Sofi S, Jan N, Shabir A, Ahmad I, Ahmad F, Almilaibary A, Mir MA. Targeting p53 misfolding conundrum by stabilizing agents and their analogs in breast cancer therapy: a comprehensive computational analysis. Frontiers in Pharmacology. 2024 Jan 10;14:1333447.","DOI":"10.3389\/fphar.2023.1333447"},{"key":"10.1016\/j.biopha.2024.117351_bib91","doi-asserted-by":"crossref","unstructured":"Jan N, Sofi S, Qayoom H, Haq BU, Shabir A, Mir MA. Targeting breast cancer stem cells through retinoids: a new hope for treatment. Critical Reviews in Oncology\/Hematology. 2023 Oct 10:104156.","DOI":"10.1016\/j.critrevonc.2023.104156"},{"issue":"1","key":"10.1016\/j.biopha.2024.117351_bib92","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/s41598-017-01659-7","article-title":"\"Cryptolepine inhibits melanoma cell growth through coordinated changes in mitochondrial biogenesis, dynamics and metabolic tumor suppressor AMPK\u03b11\/2-LKB1\"","volume":"vol. 7","author":"Pal","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2024.117351_bib93","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12906-021-03326-x","article-title":"\"Cryptolepine inhibits hepatocellular carcinoma growth through inhibiting interleukin-6\/STAT3 signalling\"","volume":"vol. 21","author":"Domfeh","year":"2021","journal-title":"BMC Complement Med Ther."},{"issue":"7","key":"10.1016\/j.biopha.2024.117351_bib94","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.3390\/ph16071026","article-title":"\"Cryptolepine Suppresses Colorectal Cancer Cell Proliferation, Stemness, and Metastatic Processes by Inhibiting WNT\/\u03b2-Catenin Signaling\"","volume":"vol. 16","author":"Quarshie","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.biopha.2024.117351_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113319","article-title":"\"Cryptolepine suppresses breast adenocarcinoma via inhibition of HIF-1 mediated glycolysis\"","volume":"vol. 153","author":"Zheng","year":"2022","journal-title":"Biomed. Pharm."},{"issue":"6","key":"10.1016\/j.biopha.2024.117351_bib96","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.374","article-title":"\"Protocol for Apoptosis Assay by Flow Cytometry Using Annexin V Staining Method\"","volume":"vol. 3","author":"Lakshmanan","year":"2013","journal-title":"Bio Protoc."},{"issue":"1-2","key":"10.1016\/j.biopha.2024.117351_bib97","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0304-3835(99)00280-3","article-title":"\"Clofilium, a potassium channel blocker, induces apoptosis of human promyelocytic leukemia (HL-60) cells via Bcl-2-insensitive activation of caspase-3\"","volume":"vol. 147","author":"Choi","year":"1999","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.biopha.2024.117351_bib98","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0014-2999(00)00805-0","article-title":"\"Cytotoxicity and cell cycle effects of the plant alkaloids cryptolepine and neocryptolepine: relation to drug-induced apoptosis\"","volume":"vol. 409","author":"Dassonneville","year":"2000","journal-title":"Eur. J. Pharm."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224012368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224012368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T23:17:45Z","timestamp":1784762265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224012368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":98,"alternative-id":["S0753332224012368"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117351","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mutant P53 modulation by cryptolepine through cell cycle arrest and apoptosis in triple negative breast cancer","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117351","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117351"}}